A Mutant ataxin-3 fragment N-terminal to amino acid 190 disease-like transgenic mice

被引:41
|
作者
Gould, Veronica F. Colomer
Goti, Daniel
Pearce, Donna
Gonzalez, Guillenno A.
Gao, Hong
De Leon, Mario Bennudez
Jenkins, Nancy A.
Copeland, Neal G.
Ross, Christopher A.
Brown, Dale R.
机构
[1] Johns Hopkins Univ Hosp, Sch Med, Dept Psychiat, Baltimore, MD 21287 USA
[2] Diag Grifols Reagents R&D Div, E-08150 Baracaldo, Spain
[3] Inst Mol & Cell Biol, Singapore 138673, Singapore
[4] Johns Hopkins Univ, Sch Med, Dept Neurosci, Dept Psychiat,Div Neurobiol, Baltimore, MD 21287 USA
[5] Johns Hopkins Univ, Sch Med, Dept Neurol, Dept Psychiat,Div Neurobiol, Baltimore, MD 21287 USA
基金
美国国家卫生研究院;
关键词
machado-joseph disease; spinocerebellar ataxia type 3; polyglutamine disease; ataxin-3; cleavage fragment; proteolysis; transgenic mouse;
D O I
10.1016/j.nbd.2007.06.005
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Machado-Joseph disease also called spinocerebellar ataxia type 3 (MJD/SCA3) is a hereditary and neurodegenerative movement disorder caused by ataxin-3 with a polyglutamine expansion (mutant ataxin-3). Neuronal loss in MJD/SCA3 is associated with a mutant ataxin-3 toxic fragment. Defining mutant ataxin-3 proteolytic site(s) could facilitate the identification of the corresponding enzyme(s). Previously, we reported a mutant ataxin-3 mjd1a fragment in the brain of transgenic mice (Q71) that contained epitopes C-terminal to amino acid 220. In this study, we generated and characterized neuroblastoma cells and transgenic mice expressing mutant ataxin-3 mjd1a lacking amino acids 190-220 (deltaQ71). Less deltaQ71 than Q71 fragments were detected in the cell but not mouse model. The transgenic mice developed an MJD/SCA3-like phenotype and their brain homogenates had a fragment containing epitopes C-terminal to amino acid 220. Our results support the toxic fragment hypothesis and narrow the mutant ataxin-3 cleavage site to the N-terminus of amino acid 190. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:362 / 369
页数:8
相关论文
共 50 条
  • [1] Mitochondrial Morphology, Function and Homeostasis Are Impaired by Expression of an N-terminal Calpain Cleavage Fragment of Ataxin-3
    Harmuth, Tina
    Prell-Schicker, Caroline
    Weber, Jonasz J.
    Gellerich, Frank
    Funke, Claudia
    Driessen, Stefan
    Magg, Janine C. D.
    Krebiehl, Guido
    Wolburg, Hartwig
    Hayer, Stefanie N.
    Hauser, Stefan
    Krueger, Rejko
    Schoels, Ludger
    Riess, Olaf
    Huebener-Schmid, Jeannette
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2018, 11
  • [2] A neuroendocrine dysfunction, not testicular mutant ataxin-3 cleavage fragment or aggregate, causes cell death in testes of transgenic mice
    Gould, VFC
    Goti, D
    Kiluk, J
    CELL DEATH AND DIFFERENTIATION, 2006, 13 (03): : 524 - 526
  • [3] A neuroendocrine dysfunction, not testicular mutant ataxin-3 cleavage fragment or aggregate, causes cell death in testes of transgenic mice
    V F Colomer Gould
    D Goti
    J Kiluk
    Cell Death & Differentiation, 2006, 13 : 524 - 526
  • [4] Silencing Mutant Ataxin-3 Rescues Motor Deficits and Neuropathology in Machado-Joseph Disease Transgenic Mice
    Nobrega, Clevio
    Nascimento-Ferreira, Isabel
    Onofre, Isabel
    Albuquerque, David
    Hirai, Hirokazu
    Deglon, Nicole
    de Almeida, Luis Pereira
    PLOS ONE, 2013, 8 (01):
  • [5] Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin
    Schilling, G
    Becher, MW
    Sharp, AH
    Jinnah, HA
    Duan, K
    Kotzuk, JA
    Slunt, HH
    Ratovitski, T
    Cooper, JK
    Jenkins, NA
    Copeland, NG
    Price, DL
    Ross, CA
    Borchelt, DR
    HUMAN MOLECULAR GENETICS, 1999, 8 (03) : 397 - 407
  • [6] A mutant ataxin-3 putative-cleavage fragment in brains of Machado-Joseph disease patients and transgenic mice is cytotoxic above a critical concentration
    Goti, D
    Katzen, SM
    Mez, J
    Kurtis, N
    Kiluk, J
    Ben-Haïem, L
    Jenkins, NA
    Copeland, NG
    Kakizuka, A
    Sharp, AH
    Ross, CA
    Mouton, PR
    Colomer, V
    JOURNAL OF NEUROSCIENCE, 2004, 24 (45): : 10266 - 10279
  • [7] Silencing of mutant ataxin-3 rescues motor deficits and neurological abnormalities in Machado-Joseph disease transgenic mice
    Nobrega, C.
    Nascimento-Ferreira, I.
    Onofre, I.
    Albuquerque, D.
    Hirai, H.
    Deglon, N.
    Pereira de Almeida, L.
    HUMAN GENE THERAPY, 2011, 22 (10) : A35 - A35
  • [8] N-terminal ataxin-3 causes neurological symptoms with inclusions, endoplasmic reticulum stress and ribosomal dislocation
    Huebener, Jeannette
    Vauti, Franz
    Funke, Claudia
    Wolburg, Hartwig
    Ye, Yihong
    Schmidt, Thorsten
    Wolburg-Buchholz, Karen
    Schmitt, Ina
    Gardyan, Adriane
    Driessen, Stefan
    Arnold, Hans-Henning
    Huu Phuc Nguyen
    Riess, Olaf
    BRAIN, 2011, 134 : 1925 - 1942
  • [9] NONINVASIVE DETECTION OF SLEEP/WAKE CHANGES IN OREXIN/ATAXIN-3 TRANSGENIC NARCOLEPTIC MICE ACROSS THE DISEASE ONSET
    Sagawa, Y.
    Hirai, N.
    Sato, S.
    Sato, M.
    Okuro, M.
    Kanbayashi, T.
    Shimizu, T.
    Nishino, S.
    SLEEP, 2012, 35 : A76 - A76
  • [10] Noninvasive detection of sleep/wake changes in orexin/ataxin-3 transgenic narcoleptic mice across the disease onset
    Sagawa, Y.
    Sato, M.
    Sato, S.
    Imanishi, A.
    Kanbayashi, T.
    Shimizu, T.
    Nishino, S.
    JOURNAL OF SLEEP RESEARCH, 2014, 23 : 260 - 260